FZD10

Across TCGA pan-cancer cohorts, FZD10 mass-spec protein is linked to patient survival in 3 of 34 cancer types, making it a survival-associated FZD10 data layer compared with 19 for mass-spec protein and 6 for mutation status.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher FZD10 mass-spec protein is associated with better disease-free survival. In most high-consensus cancer types, elevated FZD10 expression acts as an unfavorable survival marker, although some lineages such as UCEC show a favorable association.

UCEC, LUAD, and LSCC are the cancer types where FZD10 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	DFS	Median	III,IV	1.000	0.417	.042	8	view →
LUAD	OS	Quartile	All	0.509	0.868	.024	8	view →
LSCC	DFS	Quartile	All	0.268	0.807	.038	2	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

FZD10–UCEC (DFS)

Open the UCEC breakdown →